Chloride Channel Activator Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Chloride Channel Activator
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 209450-001 | Nov 30, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Amneal | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 209450-002 | Nov 30, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Zydus Pharms | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 214131-001 | Mar 23, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Zydus Pharms | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 214131-002 | Mar 23, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Teva Pharms Usa Inc | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 209920-001 | Jan 18, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Teva Pharms Usa Inc | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 209920-002 | Jan 18, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
